logo

For the Inventor, By the Inventor

Los Altos, CA, United States of America

Retrotope, Inc.

Calculating rank
USPTO Granted Patents = 25



Forward Citations = 61

Loading Chart...
Loading Chart...

3 inventors (with patents filed for the assignee):

goldMedal Mikhail Sergeevich Shchepinov (25 out of 37 patents)

silverMedal Dragoslav Vidovic (4 out of 6 patents)

bronzeMedal Peter G Milner (3 out of 41 patents)

4.  Mikhail S Shchepinov (0 patent)


Core Competencies:
Oxidative Stress
Neurodegenerative Diseases
PUFA Derivatives
Isotopic Labeling
Amyotrophic Lateral Sclerosis
Retinal Diseases
Mitochondrial Deficiency
Genome Methylation
Therapeutic Uses
Food Supplements
Energy Processing Disorders
Cancer Therapies

25 patents:

1. 11510889 - Methods for inhibiting the progression of neurodegenerative diseases (2022-11-29),
2. 11510888 - Alleviating oxidative stress disorders with PUFA derivatives (2022-11-29),
3. 11491130 - Methods of treating amyotrophic lateral sclerosis (2022-11-08),
4. RE49238 - Alleviating oxidative stress disorders with PUFA derivatives (2022-10-10),
5. 11453637 - Site-specific isotopic labeling of 1,4-diene systems (2022-09-27),
6. 11447441 - Site-specific isotopic labeling of 1,4-diene systems (2022-09-20),
7. 11351143 - Methods of treating amyotrophic lateral sclerosis (2022-06-07),
8. 11285125 - Oxidative retinal diseases (2022-03-29),
9. 11241409 - Neurodegenerative disorders and muscle diseases implicating PUFAs (2022-02-08),
10. 11166930 - Isotopically modified components and therapeutic uses thereof (2021-11-09),
11. 10918126 - Isotopically modified compounds and their use as food supplements (2021-02-16),
12. 10730821 - Site-specific isotopic labeling of 1,4-diene systems (2020-08-04),
13. 10577304 - Site-specific isotopic labeling of 1,4-diene systems (2020-03-03),
14. 10154983 - Neurodegenerative disorders and muscle diseases implicating PUFAs (2018-12-18),
15. 10154978 - Disorders implicating PUFA oxidation (2018-12-18),
Company Overview
Retrotope, Inc. is a biotechnology company based in Los Altos, California, specializing in the development of innovative therapies that target age-related diseases and conditions. The company focuses on harnessing the potential of stable isotopes to create novel treatments aimed at improving healthspan and addressing the underlying mechanisms of aging. Retrotope's research encompasses a range of therapeutic areas, leveraging advanced scientific insights to enhance patient outcomes and promote longevity.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Retrotope, Inc. USPTO Patent Assignee Logo
25 Patents

#8 in Los Altos, CA

#3,162 in California

#13,379 in US

#25,748 in the World

Los Altos, CA (US)
Los Altos, CA, United States of America

Retrotope, Inc.

Forward Citations = 61

3 inventors:

goldMedal Mikhail Sergeevich Shchepinov (25 out of 37 patents)

silverMedal Dragoslav Vidovic (4 out of 6 patents)

bronzeMedal Peter G Milner (3 out of 41 patents)

4.  Mikhail S Shchepinov (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Retrotope, Inc.. Retrieved from https://idiyas.com/company/retrotope

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…